Advertisement

Topics

2017 France Infectious Disease Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review [Updated: 30032017] Prices from USD $4350

08:39 EDT 6 Jun 2017 | BioPortfolio Reports

Complete report $4,350. nbsp;DataPack test volumes, sales forecasts, supplier shares $2,800.nbsp; The reportnbsp;is available by section, market segment, individual test, and can be customtailored to your specific information needs and budget.

This new study from VPGMarketResearchnbsp;contains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnosticsnbsp;market during the next five years.

Report Highlights

Business and technological trends in major markets

Fiveyear test volume and sales forecasts

Market shares of leading competitors

Feature comparison of major analyzers

Strategic profiles of leading market players and startup firms developing innovative products

Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of costeffective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

France Market Overview

Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment.

Fiveyear test volume and sales projections.

Market Segmentation Analysis

Sales and market shares of leading suppliers of infectious disease molecular diagnostic
nbsp; reagent kits and components.

Fiveyear test volume and sales projections for over 40 infectious disease molecular diagnostic assays.

A comprehensive analysis of the sequencing market by country and laboratory segment.

Detailed market segmentation analysis, including review of the market dynamics, trends,
nbsp; structure, size, growth and major suppliers.

Product/Technology Review

Comparison of leading infectious disease molecular diagnosticnbsp;analyzers.

Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
nbsp; trends in testing automation and over target/signal amplification methods.

Worldwide listings of companies, universities and research centers developing new molecular
nbsp; diagnosticnbsp;technologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants,
nbsp;nbsp;including their sales, product portfolios, marketing tactics, collaborative arrangements
nbsp; and new technologies/products in Ramp;D.

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
BioRad
Biotest
CellMark Forensics/LabCorp
Cepheid
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/GenProbe
Illumina
Kreatech
LiCor Biosciences
Monogram Biosciences/LabCorp
Myriad Genetics
OrthoClinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

Comprehensive listings of companies developing and marketing infectious disease molecular
nbsp; diagnostic products, by test and application.

Opportunities and Strategic Recommendations

Specific new product development opportunities with potentially significant market appeal
nbsp;nbsp;during the next five years.

Design criteria for new products.

Alternative market penetration strategies.

Potential market entry barriers and risks.

Business planning issues and concerns.

Contains 615 pages and 26 tables

Original Article: 2017 France Infectious Disease Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review [Updated: 30032017] Prices from USD $4350

NEXT ARTICLE

More From BioPortfolio on "2017 France Infectious Disease Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review [Updated: 30032017] Prices from USD $4350"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...